NCT06261671 Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates.
| NCT ID | NCT06261671 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ART Fertility Clinics LLC |
| Condition | Infertility |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2024-02-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
One of the most sensible factors in IVF culture conditions is the susceptibility of gametes and embryos to an induced increase in reactive oxidative species (ROS) caused by the artificial environment. This study aims to evaluate the impact of using antioxidant-supplemented media during culture to evaluate embryo ploidy rates in a prospective randomized trial using sibling oocytes.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing assisted reproductive technology cycles when ICSI is indicated. * Patients when Iin vitto fertilization (IVF) is also performed will be included as far as there are enough oocytes for ICSI randomization. However, IVF oocytes will not be used for the study. * Maternal age 18-43 years old. * PGT-A cycles with only trophectoderm biopsies on day 5/6/7. * Patients with more than 6 COCs expected for ICSI. * Body mass index \<35. * Fresh and frozen ejaculated sperm. Exclusion Criteria: * PGT-M cycles * Fresh and frozen testicular sperm.
Contact & Investigator
Barbara Lawrenz
STUDY DIRECTOR
ART Fertility Clinics LLC
Frequently Asked Questions
Who can join the NCT06261671 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 43 Years, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06261671 currently recruiting?
Yes, NCT06261671 is actively recruiting participants. Contact the research team at daniela.nogueira@artfertilityclinics.com for enrollment information.
Where is the NCT06261671 trial being conducted?
This trial is being conducted at Abu Dhabi, United Arab Emirates.
Who is sponsoring the NCT06261671 clinical trial?
NCT06261671 is sponsored by ART Fertility Clinics LLC. The principal investigator is Barbara Lawrenz at ART Fertility Clinics LLC. The trial plans to enroll 500 participants.